Value Investor Wally Weitz Sells Off Remaining Valeant Stake

Updated on
  • Statement cites drug company's pricing, business practices
  • Firm calls investment ``very profitable'' over four years

Wally Weitz, a value investor from Warren Buffett’s home town of Omaha, Nebraska, said his firm exited its remaining investment in Valeant Pharmaceuticals International Inc.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.